Skip to main content
Log in

Interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum in vitro

Interaktion zwischen Lumefantrin und Monodesbutyl-Benflumetol bei Plasmodium falciparum in vitro

  • Original Article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Zusammenfassung

Die pharmakodynamische Interaktion zwischen Lumefantrin und seinem Monodesbutyl-Analog (DBB) wurde bei 35 frischen Isolaten von Plasmodium falciparum untersucht. Beide Substanzen zeigten signifikante Wirkungskorrelation. Die geometrischen Mittelwerte für volle Hemmung der Schizontenreifung (GMCOC) lagen bei 536,8 nM für Lumefantrin, 246,0 nM für DBB, 235,5 nM für LUM-DBB 999:1, und 155,2 nM für LUM-DBB 995:5, mit signifikanten Unterschieden zwischen Lumefantrin und DBB sowie den LUM-DBB Kombinationen. Die Summen der fraktionellen Hemmwerte nach Berenbaum (SFIC) lagen für LUM-DBB 995:5 im Bereich von klarem Synergismus, wobei der Interaktionsgrad mit der effektiven Hemmkonzentration stieg.

Summary

The pharmacodynamic interaction between lumefantrine and its monodesbutyl analogue (DBB) has been investigated in 35 fresh isolates of Plasmodium falciparum. Both compounds showed highly significant activity correlation. The geometric mean values for complete inhibition of schizont maturation (GMCOC) were 536,8 nM for lumefantrine, 246.0 nM for DBB, 235,5 nM for LUM-DBB 999:1, and 155,2 nM for LUM-DBB 995:5, with significant activity differences between lumefantrine and DBB as well as the LUM-DBB combinations. For the combination of lumefantrine and DBB 995:5 the sums of the fractional inhibitory concentrations according to Berenbaum (SFIC) indicated marked synergism, the intensity of interaction rising with the effective inhibitory concentrations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • World Health Organization (1990) Practical chemotherapy of malaria. Report of a WHO Scientific Group. WHO Tech Rep Ser 805, WHO, Geneva, pp 124–126

  • Yeung S, Pongtavompinyo W, Hastings IM, Mills AJ, White NJ (2004) Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modelling to elucidating policy choices. Am J Trop Med Hyg 71 [Suppl 2]: 179–186

    PubMed  Google Scholar 

  • Noedl H, Allmendinger T, Prajakwong S, Wernsdorfer G, Wernsdorfer WH (2001) Desbutyl-benflumetol, a novel antimalarial compound: in vitro activity in fresh isolates of Plasmodium falciparum from Thailand. Antimicrob Agents Chemother 45: 2106–2109

    Article  PubMed  CAS  Google Scholar 

  • Starzengruber P, Wernsdorfer G, Parizek M, Rojanawatsirivet C, Kollaritsch H, Wernsdorfer WH (2007) Specific pharmacokinetic interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum. Wien Klin Wochenschr 119 [Suppl 3]: 60–66

    Article  CAS  Google Scholar 

  • Pirker-Krassnig DK, Wernsdorfer G, Sirichaisinthop J, Rojanawatsirivet C, Kollaritsch H, Wernsdorfer WH (2004) Comparative study on the in vitro activity of lumefantrine and debutyl-benflumetol in fresh isolates of Plasmodium vivax from Thailand. Wien Klin Wochenschr 116 [Suppl 4]: 47–52

    PubMed  Google Scholar 

  • World Health Organization (1991) Basic malaria microscopy. Part I. WHO, Geneva, pp 67–68

  • Litchfield JT jr, Wilcoxon F (1949) A simplified method for evaluating dose-effect experiments. J Pharm Exp Ther 96: 99–113

    CAS  Google Scholar 

  • Wernsdorfer WH, Wernsdorfer MG (1995) The evaluation of in vitro tests for the assessment of drug response in Plasmodium falciparum. Mitteilungen Oesterr Gesellsch Tropenmed Parasitol 17: 221–228

    Google Scholar 

  • Berenbaum MC (1978) A method for testing for synergy with any number of agents. J Infect Dis 137: 122–130

    PubMed  CAS  Google Scholar 

  • Lefèvre G, Thomsen MS (1999) Clinical pharmacokinetics of artemether and lumefantrine (Riamet®). Clin Drug Invest 18: 467–480

    Article  Google Scholar 

  • Wernsdorfer WH (2004) Coartemether (artemether and lumefantrine): an oral antimalarial drug. Expert Rev Anti-infect Ther 2: 181–196

    Article  PubMed  CAS  Google Scholar 

  • Traebert M, Dumotier B, Meister L, Hoffmann P, Dominguez-Estevez M, Suter M (2004) Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. Eur J Pharmacol 484: 41–48

    Article  PubMed  CAS  Google Scholar 

  • Wernsdorfer G, Wernsdorfer WH (2003) Malaria at the turn from the 2nd to the 3rd millennium. Wien Klin Wochenschr 115 [Suppl 3]: 2–9

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Starzengruber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Starzengruber, P., Kollaritsch, H., Sirichaisinthop, J. et al. Interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum in vitro. Wien Klin Wochenschr 120 (Suppl 4), 85–89 (2008). https://doi.org/10.1007/s00508-008-1080-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-008-1080-8

Keywords

Navigation